< Back to latest news & events

Event

IAM Live: IP and Emerging Technology Europe 2023

February 2023

Event date: 19th April 2023

HGF is a gold sponsor of IAM Live: IP and Emerging Technology Europe 2023 on the 19th April in London.

The rise of AI is changing the way high-tech innovations are protected, posing new questions about inventorship and patentability, and increasing the value of data as an intangible asset. Meanwhile, convergence between industry sectors is producing new patterns of, and opportunities for, IP dealmaking. This event will provide expert insights into the latest IP developments relating to the Internet of Things, digital healthcare, connectivity in the age of 5G and 6G, AI, blockchain and the metaverse.

HGF Partner and Patent Attorney Matt Cassie will be moderating the panel ‘IP strategies in the age of technology convergence‘. This panel will cover ‘ how the changing tech landscape is creating new opportunities for IP dealmaking. Discover how convergence is affecting specific industries and find out how to realise the value of your innovations as traditional technology lines are blurred.

  • Developing your IP portfolio for emerging technologies
  • Capitalising on new licensing opportunities in diverse sectors
  • Exploring implications of increased collaboration between industries’. 

HGF Patent Directors Sofie McPherson & Nick King will be in attendance at the event.

FIND OUT MORE

Attendees

Nick
King

Sofie
McPherson

Latest updates

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article

IAM Global Leaders 2026

HGF is proud to announce that we have 3 partners listed as an IAM Global Leader 2026. To qualify for inclusion in the IAM Global Leaders, individuals must be ranked …

Read article

The Bite of Implied Consent: Lessons from the Pink Lady Case

A recent European Union court decision considers the issue of implied consent to commercialise a plant variety, and whether the evidence meets the threshold of “serious doubts” of the validity …

Read article
Event - 5th November 2025

HGF are Gold Sponsors of IAM Live: Navigating the UPC 2025

We’re excited to share that HGF is a Gold Sponsor of IAM Live: Navigating the UPC 2025, taking place on the 5th November at the Marriott Opera Ambassador Hotel in …

Event details

HGF ranked band 1 in Chambers and Partners UK 2026

The Chambers and Partners UK 2026 Guide is now live and HGF has one again been highly ranked as a firm, with several recognised individuals across multiple regions. HGF is …

Read article

How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

Read article
Event - 14th October 2025

The Future of Protein Production Amsterdam 2025

HGF are proud to be sponsoring the Future of Protein Production Amsterdam 2025, the leading global event bringing together innovators across fermentation, cultivated and plant-based proteins. Date: 29-30th October 2025  …

Event details

A Turning Point for AI Patent Eligibility?

Director Squires Vacates PTAB § 101 Rejection in DeepMind Case In a notable early move as Under Secretary of Commerce and USPTO Director, John Squires has vacated a Patent Trial …

Read article
See all updates